Avid Bioservices, Inc. (CDMO)

Market Cap	425.31M
Revenue (ttm)	139.91M
Net Income (ttm)	-140.75M
Shares Out	63.48M
EPS (ttm)	-2.23
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	752,009
Open	7.18
Previous Close	7.12
Day's Range	6.62 - 7.18
52-Week Range	4.07 - 14.28
Beta	1.51
Analysts	Buy
Price Target	12.50 (+86.57%)
Earnings Date	Jul 2, 2024

About CDMO

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services of biologics for the biotechnology and biopharmaceutical industries. The company offers various services, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream deve...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1981
• Employees: 365
• Stock Exchange: NASDAQ
• Ticker Symbol: CDMO

Analyst Forecast

According to 5 analysts, the average rating for CDMO stock is "Buy." The 12-month stock price forecast is $12.5, which is an increase of 86.57% from the latest price.

Price Target

$12.5

(86.57% upside)

Analyst Consensus: Buy